Triage

Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024

Retrieved on: 
Thursday, February 29, 2024

The flexible X-ray CT system increases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.

Key Points: 
  • The flexible X-ray CT system increases diagnostic confidence, streamlines workflow efficiency, and maximizes system up-time, helping to improve patient outcomes and department productivity.
  • However, a lack of availability of high-quality CT systems, or physicians qualified to read cardiac CT exams, often prevents this approach.
  • The Philips CT 5300 system meets advanced diagnostic imaging requirements for cardiac care patient guidelines, as well as for other challenging areas such as trauma care and interventional procedures.
  • Emphasizing lifetime value and sustainability, the CT 5300 is designed to lower energy consumption.

Bottomline Unveils Enhanced Internal Threat Management Solution

Retrieved on: 
Thursday, February 22, 2024

The enhanced solution supports organizations to better use data visualizations, threat profiles and advanced case management strategies in fighting insider fraud.

Key Points: 
  • The enhanced solution supports organizations to better use data visualizations, threat profiles and advanced case management strategies in fighting insider fraud.
  • Already making headlines, Bottomline’s Internal Threat Management Solution (ITM) was recently named the market leader in Quadrant Knowledge Solution’s 2023 Spark Matrix™ for Insider Risk Management.
  • Our newly enhanced Insider Threat Management solution brings this reality to the forefront.
  • Whether an internal threat is malicious or unintentional, the technology visually maps connections between unusual activities and users, expediting the detection of insider activity, including external fraud initiated from within.

CLARA Analytics Achieves Record Revenue Growth, Accelerates Innovation

Retrieved on: 
Wednesday, March 6, 2024

The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.

Key Points: 
  • The platform includes CLARA Triage , CLARA Treatment , CLARA Litigation , CLARA Optics and CLARA MSP Compliance modules, which enable claims professionals to choose specific capabilities to tackle their rising insurance claims challenges.
  • “Investors, industry leaders, and analysts are responding extremely positively to CLARA’s rapid growth and customer success,” said CLARA Analytics CEO Heather H. Wilson .
  • Last month, CLARA announced yet another infusion of capital from Nationwide Ventures , which invests in companies that are shaping the future of insurance and financial services.
  • CLARA’s growth is fueled by its track record of delivering strong ROI for its customers, along with its reputation for industry-leading innovation and customer service.

QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada

Retrieved on: 
Wednesday, March 6, 2024

QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.

Key Points: 
  • QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.
  • The Triage PLGF test is a fluorescence immunoassay to be used with the small footprint Triage MeterPro® Instrument for the quantitative determination of placental growth factor (“PLGF”) in maternal plasma specimens.
  • With the Triage PLGF test, clinicians can be positioned to better detect angiogenic imbalance and assess the risk for these complications.
  • The Triage PLGF test is available to customers in Canada for use with the Triage MeterPro instrument.

New UC Berkeley Center Aims to Create Healthcare Innovation Research-to-Impact Pipeline

Retrieved on: 
Wednesday, March 6, 2024

Developing and using the research on healthcare innovation incentives will lead to the creation and deployment of interventions that meaningfully improve public health.

Key Points: 
  • Developing and using the research on healthcare innovation incentives will lead to the creation and deployment of interventions that meaningfully improve public health.
  • The new Berkeley center aims to play an essential role in ensuring those innovations benefit the public.
  • The center aims to connect expertise in behavioral economics with advanced research and development at Berkeley to help develop healthcare solutions that people and companies want and will harness.
  • “I’m very excited to see some of Berkeley’s great minds and cutting-edge resources come together at the new Center for Healthcare Marketplace Innovation.”

Bitdefender Launches Powerful Endpoint Protection and Security Service Solutions Tailored for Managed Service Providers

Retrieved on: 
Tuesday, March 5, 2024

Bitdefender GravityZone Cloud MSP Security Solutions is powered by the GravityZone Platform , a unified security and risk analytics platform that provides advanced endpoint protection including endpoint detection and response (EDR), extended detection and response (XDR) and cloud security for physical, virtual, and multi-cloud environments.

Key Points: 
  • Bitdefender GravityZone Cloud MSP Security Solutions is powered by the GravityZone Platform , a unified security and risk analytics platform that provides advanced endpoint protection including endpoint detection and response (EDR), extended detection and response (XDR) and cloud security for physical, virtual, and multi-cloud environments.
  • GravityZone Cloud MSP Security Solutions is offered in multiple tiers including Secure, Secure Plus, and Secure Extra - each providing best-in-class security protection yet tailored to fit an MSP customers’ specific needs, requirements (including compliance) and budgets.
  • Bitdefender is renowned for its excellence in threat protection consistently ranking number one in independent third-party tests including AV-Comparatives and MITRE ATT&CK .
  • MSP partner Blaze Networks touts Bitdefender endpoint protection and MDR capabilities stating, “Bitdefender’s MDR offering gives me peace of mind.

One Mind™ Accelerator Announces Second Cohort of Mental Health Startups

Retrieved on: 
Monday, March 4, 2024

One Mind™ , a leading mental health non-profit based in Napa Valley, CA, today announced the 2024 cohort of its flagship One Mind Accelerator program.

Key Points: 
  • One Mind™ , a leading mental health non-profit based in Napa Valley, CA, today announced the 2024 cohort of its flagship One Mind Accelerator program.
  • By supporting emerging companies through the Accelerator, One Mind seeks to positively impact the lives of people facing mental health challenges by advancing precision psychiatry, and making high quality mental healthcare more accessible, affordable, and equitable.
  • This is the second cohort for the One Mind Accelerator since the program’s launch in 2023.
  • Cerula Care is a virtual behavioral healthcare practice that partners with specialists and tailors behavioral health care for adults with serious illness.

Fujirebio Europe Expands Its Portfolio With Introduction of the Innovative PreCursor-M AnoGYN assay (RUO) for Methylation Testing in Anal Specimens

Retrieved on: 
Tuesday, March 5, 2024

Also in this HPV-related cancer, methylation appears to be promising for future use as an accurate biomarker for objective risk stratification of anal lesions.

Key Points: 
  • Also in this HPV-related cancer, methylation appears to be promising for future use as an accurate biomarker for objective risk stratification of anal lesions.
  • In analogy with cervical cancer screening, the screening and treatment of HSIL to prevent anal cancer in high-risk groups are under debate.
  • Host cell deoxyribonucleic acid methylation markers for the detection of high-grade anal intraepithelial neoplasia and anal cancer.
  • Analytical validation and diagnostic performance of the ASCL1/ZNF582 methylation test for detection of high-grade anal intraepithelial neoplasia and anal cancer.

CI&T Advances the Digital Health Ecosystem for Patients and Providers at HIMSS24

Retrieved on: 
Thursday, February 29, 2024

CI&T partners with some of the largest pharmaceutical, consumer healthcare and medical device companies in the world to help create innovative digital experiences for patients and healthcare professionals.

Key Points: 
  • CI&T partners with some of the largest pharmaceutical, consumer healthcare and medical device companies in the world to help create innovative digital experiences for patients and healthcare professionals.
  • From HCP Engagement and Digital Front Door solutions to Patient Triage through AI, CI&T offers clients unique cross-channel solutions for their challenges for the entire journey of patients, practitioners, and payors.
  • “ Can AI Fix the Health System ” will explore how AI can help orchestrate a seamless health ecosystem that elevates patient experience and drives improved outcomes.
  • Immersive Solution for HCP Training – An immersive AR experience for training doctors using digital twins, personalized training journeys and remote mentoring.

Splunk Announces Fiscal Fourth Quarter and Full Year 2024 Financial Results

Retrieved on: 
Tuesday, February 27, 2024

Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, today announced results for its fiscal fourth quarter and full year ended January 31, 2024, as compared to the corresponding period of the last fiscal year:

Key Points: 
  • Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, today announced results for its fiscal fourth quarter and full year ended January 31, 2024, as compared to the corresponding period of the last fiscal year:
    Total ARR was $4.208 billion, up 15%; Cloud ARR was $2.186 billion, up 23%.
  • Visit the Splunk investor relations website to download the company’s quarterly investor presentation, which includes Splunk President and CEO Gary Steele’s letter to stockholders.
  • In light of the pending transaction with Cisco, Splunk will not be hosting an earnings conference call to review the fourth quarter or providing a financial outlook.
  • Splunk Security Innovations Strengthen Digital Resilience: Splunk delivered Splunk Enterprise Security 7.3 to provide an enhanced security analyst experience as well as enrich risk context for seamless security incident triage.